BIB vs. RDYY

Last updated Jul 18, 2026

BIB (ProShares Ultra Nasdaq Biotechnology) and RDYY (YieldMax RDDT Option Income Strategy ETF) are both exchange-traded funds - BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%), while RDYY is a Derivative Income fund actively managed by YieldMax. BIB is passively managed, while RDYY is actively managed. At a 0.16 correlation, their price movements are largely independent. BIB charges 0.95%/yr vs 0.99%/yr for RDYY.

Performance

BIB vs. RDYY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Nasdaq Biotechnology (BIB) and YieldMax RDDT Option Income Strategy ETF (RDYY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BIB achieves a 25.46% return, which is significantly higher than RDYY's -17.89% return.

BIB

• 1D: 0.33%
• 1M: 17.81%
• 6M: 23.83%
• YTD: 25.46%
• 1Y: 98.60%
• 3Y*: 24.35%
• 5Y*: 2.01%
• 10Y*: 9.22%

RDYY

• 1D: -1.54%
• 1M: 6.90%
• 6M: -17.39%
• YTD: -17.89%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BIB vs. RDYY - Yearly Performance Comparison

	2026 (YTD)	2025
BIB ProShares Ultra Nasdaq Biotechnology	25.46%	38.05%
RDYY YieldMax RDDT Option Income Strategy ETF	-17.89%	-5.31%

Correlation

The correlation between BIB and RDYY is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Sep 9, 2025	0.16

Return for Risk

BIB vs. RDYY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIB

BIB Risk / Return Rank: 88
BIB Sharpe Ratio Rank: 91
BIB Sortino Ratio Rank: 84
BIB Omega Ratio Rank: 77
BIB Calmar Ratio Rank: 95
BIB Martin Ratio Rank: 92

RDYY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIB vs. RDYY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and YieldMax RDDT Option Income Strategy ETF (RDYY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BIB	RDYY	Difference
Sharpe ratio: Return per unit of total volatility	2.45	—	—
Sortino ratio: Return per unit of downside risk	3.03	—	—
Omega ratio: Gain probability vs. loss probability	1.36	—	—
Calmar ratio: Return relative to maximum drawdown	5.86	—	—
Martin ratio: Return relative to average drawdown	17.48	—	—

Drawdowns

BIB vs. RDYY - Drawdown Comparison

The maximum BIB drawdown since its inception was -67.24%, which is greater than RDYY's maximum drawdown of -51.16%. Use the drawdown chart below to compare losses from any high point for BIB and RDYY.

Drawdown Indicators

	BIB	RDYY	Difference
Max Drawdown Largest peak-to-trough decline	-67.24%	-51.16%	-16.08%
Max Drawdown (1Y) Largest decline over 1 year	-16.92%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-45.30%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-65.86%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-66.20%	—	—
Current Drawdown Current decline from peak	-8.88%	-29.97%	+21.09%
Average Drawdown Average peak-to-trough decline	-32.60%	-28.70%	-3.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.67%	—	—

Volatility

Volatility by Period

	BIB	RDYY	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.63%	—	—
Volatility (6M) Calculated over the trailing 6-month period	31.56%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	40.52%	55.49%	-14.97%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.76%	55.49%	-11.73%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	46.32%	55.49%	-9.17%

BIB vs. RDYY - Expense Ratio Comparison

BIB has a 0.95% expense ratio, which is lower than RDYY's 0.99% expense ratio.

Dividends

BIB vs. RDYY - Dividend Comparison

BIB's dividend yield for the trailing twelve months is around 0.32%, less than RDYY's 100.87% yield.

Position	TTM	2025	2024	2023	2022
BIB ProShares Ultra Nasdaq Biotechnology	0.32%	0.77%	1.69%	0.07%	0.03%
RDYY YieldMax RDDT Option Income Strategy ETF	100.87%	25.20%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BIB and RDYY in my portfolio?

BIB and RDYY have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, BIB or RDYY?

On fees, BIB is cheaper at 0.95% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, BIB or RDYY?

BIB is cheaper with a 0.95% expense ratio, compared with 0.99% for RDYY.

Which ETF pays a higher dividend yield, BIB or RDYY?

RDYY has the higher dividend yield at 100.87%, compared with 0.32% for BIB.

What is the main difference between BIB and RDYY?

BIB is categorized as Leveraged Equities, while RDYY is Derivative Income. They also come from different issuers: ProShares and YieldMax. Their fees differ too: 0.95% for BIB and 0.99% for RDYY.